Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Latrofa

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Endocrine-Related Cancer|April 12, 2023
Thyroid autoimmunity, thyroglobulin autoantibodies, and thyroid cancer prognosisNicola Viola, Laura Agate, Sonia Caprio, et al.
Thyroid : Official Journal of the American Thyroid Association|October 18, 2012
Rehabilitative orbital decompression for Graves' orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome, and patients' satisfactionRoberto Rocchi, Riccardo Lenzi, Michele Marinò, et al.
The Journal of Clinical Endocrinology and Metabolism|June 2, 2023
Cytological and Ultrasound Features of Thyroid Nodules Correlate With Histotypes and Variants of Thyroid CarcinomaDaniele Sgrò, Alessandro Brancatella, Giuseppe Greco, et al.
Journal of Endocrinological Investigation|March 21, 2025
Serum levels of rapamycin predict the response of Graves' orbitopathy to sirolimusSimone Comi, Giada Cosentino, Elena Sabini, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 13, 2016
VARIABLES AFFECTING THE LONG-TERM OUTCOME OF GRAVES ORBITOPATHY FOLLOWING HIGH-DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPYMarenza Leo, Teresa Mautone, Ilaria Ionni, et al.
European Journal of Endocrinology|February 10, 2015
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological studyEleonora Sisti, Barbara Coco, Francesca Menconi, et al.
Thyroid : Official Journal of the American Thyroid Association|November 5, 2016
Low Elasticity of Thyroid Nodules on Ultrasound Elastography Is Correlated with Malignancy, Degree of Fibrosis, and High Expression of Galectin-3 and Fibronectin-1Teresa Rago, Maria Scutari, Valeria Loiacono, et al.
Thyroid : Official Journal of the American Thyroid Association|October 24, 2012
Thyroid volume and severity of Graves' orbitopathyMaria Antonietta Profilo, Eleonora Sisti, Claudio Marcocci, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 2019
Fifty Years After the First Description, MEN 2B Syndrome Diagnosis Is Still Late: Descriptions of Two Recent CasesRossella Elisei, Antonio Matrone, Laura Valerio, et al.
Endocrine|March 29, 2025
In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' orbitopathyGiulia Lanzolla, Giovanna Rotondo Dottore, Simone Comi, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Endocrine-Related Cancer|April 12, 2023
Thyroid autoimmunity, thyroglobulin autoantibodies, and thyroid cancer prognosisNicola Viola, Laura Agate, Sonia Caprio, et al.
Thyroid : Official Journal of the American Thyroid Association|October 18, 2012
Rehabilitative orbital decompression for Graves' orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome, and patients' satisfactionRoberto Rocchi, Riccardo Lenzi, Michele Marinò, et al.
The Journal of Clinical Endocrinology and Metabolism|June 2, 2023
Cytological and Ultrasound Features of Thyroid Nodules Correlate With Histotypes and Variants of Thyroid CarcinomaDaniele Sgrò, Alessandro Brancatella, Giuseppe Greco, et al.
Journal of Endocrinological Investigation|March 21, 2025
Serum levels of rapamycin predict the response of Graves' orbitopathy to sirolimusSimone Comi, Giada Cosentino, Elena Sabini, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 13, 2016
VARIABLES AFFECTING THE LONG-TERM OUTCOME OF GRAVES ORBITOPATHY FOLLOWING HIGH-DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPYMarenza Leo, Teresa Mautone, Ilaria Ionni, et al.
European Journal of Endocrinology|February 10, 2015
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological studyEleonora Sisti, Barbara Coco, Francesca Menconi, et al.
Thyroid : Official Journal of the American Thyroid Association|November 5, 2016
Low Elasticity of Thyroid Nodules on Ultrasound Elastography Is Correlated with Malignancy, Degree of Fibrosis, and High Expression of Galectin-3 and Fibronectin-1Teresa Rago, Maria Scutari, Valeria Loiacono, et al.
Thyroid : Official Journal of the American Thyroid Association|October 24, 2012
Thyroid volume and severity of Graves' orbitopathyMaria Antonietta Profilo, Eleonora Sisti, Claudio Marcocci, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 2019
Fifty Years After the First Description, MEN 2B Syndrome Diagnosis Is Still Late: Descriptions of Two Recent CasesRossella Elisei, Antonio Matrone, Laura Valerio, et al.
Endocrine|March 29, 2025
In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' orbitopathyGiulia Lanzolla, Giovanna Rotondo Dottore, Simone Comi, et al.
Pageof 7